-
Event
18 - 19 November 2026, Brussels & online
Strengthening Cancer Care: Securing a Healthy, Equitable, Resilient and Competitive Europe
Amid political instability, economic pressure, and the risk of escalating conflict, discussions around Europe’s next multiannual budget are intensifying in Brussels and in capitals across the EU.
In this environment, addressing the growing burden of cancer is essential. This unrelenting disease is not only a public health priority, but a strategic investment in Europe’s resilience, social cohesion and long‑term competitiveness.
As Europe defines its political priorities for the decade ahead, health and cancer must be embedded at the heart of future investments. At this critical moment, the cancer community must champion a vision for a resilient, equitable and innovative Europe.
The European Cancer Summit 2026 will take place in Brussels & online on 18-19 November, followed by EU-funded project events on 20 November. Registrations will open soon.
Read more
-
Event
30 June 2026, Online
Joint Stakeholder Forum of the PanCare4AYA, PredictAYA and STRONG-AYA projects
How can research help strengthen age-appropriate cancer care for adolescents and young adults (AYAs) across Europe?
That’s the focus of an upcoming stakeholder forum featuring three dedicated EU projects: PanCare4AYA, PredictAYA, and STRONG-AYA.
Join this online event for a wide ranging discussion.
Tuesday 30 June, 15:00-17:00 CEST.
Register here to take part!
Read more
-
news
26 May 2026
Each year in Europe, 2 million lives are lost due to cancer. Many of them could have been saved through early detection.
Early detection can raise survival rates by up to 13 times for some common cancers, while late detection can lead to less than 10% survival after five years.
This European Week Against Cancer, on the day dedicated to early detection of cancer, the European Cancer Organisation unveils the new 2026 European Cancer Screening Policy Index, calling attention to the urgent need for stronger and more equitable cancer screening policies across the continent.
Read more
-
Publication
May 2026
Every year, 2 million lives are lost due to cancer, many of them because the disease was detected too late. Early detection can raise survival rates by up to 13 times for some common cancers, while late detection can lead to less than 10% survival after five years.
Evidence-based cancer screening implementation remains one of the most effective ways to improve cancer outcomes, yet major disparities in policies and participation persist across Europe.
Read more
-
news
11 May 2026
Bucharest, 11 May – Eliminating cervical cancer and at least six other cancers caused by the human papillomavirus (HPV) requires everyone to play their part – and through popular sports, we’re bringing this message to a vast and varied audience.
Read more
-
reports
April 2026
Treating cancer effectively means addressing more than the disease alone. ECO’s report Treating the Whole Patient highlights three often under-addressed dimensions of cancer care that are essential to patient outcomes, safety and quality of life: medical nutrition, antimicrobial resistance, and healthcare-acquired infections. Despite their importance, these areas remain too often overlooked in policy and practice across Europe.
Read more
-
reports
April 2026
The European Cancer Organisation convenes oncology professionals and patient groups to develop policies, advocate for change and speak up for the European cancer community.
Read more
-
news
30 March 2026
In November 2024, the European Cancer Organisation (ECO) published Under Pressure: Safeguarding the health of Europe’s oncology workforce, a report on the working conditions of cancer care professionals across Europe. Since then, its policy recommendations have led the cancer community in a call for comprehensive measures to improve the work environment.
Read more
-
news
24 March 2026
Brussels, Belgium – 24 March 2026 – Policymakers, clinicians, patient advocates and public health experts gathered today at the European Parliament to discuss how eliminating viral hepatitis can dramatically reduce liver cancer across Europe.
Read more
